Medical Developments International (ASX:MVP) — Material Events
ASX:MVP · 7 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Medical Developments International Posts FY25 Profit Turnaround and Paediatric ApprovalHigh
Medical Developments International posts FY25 profit turnaround and secures paediatric approval for Penthrox
21 Aug 2025
·Full Year Results
·Unexpected
·85
MVP’s FY25 Surge, Revenue Up 18%, Eyes on Penthrox Volume GrowthMedium
MVP posts strong FY25 revenue growth and margin gains; focuses on accelerating Penthrox volume growth in FY26
21 Aug 2025
·Full Year Results
·85
Medical Developments International Posts 18% Revenue Growth, Returns to ProfitHigh
Medical Developments International posts 18% revenue growth, returns to profit, and advances Penthrox market expansion
21 Aug 2025
·Preliminary Final Report and Annual Financial Report
·85
Medical Developments International Boosts Penthrox Sales and Advances Paediatric ApprovalMedium
Medical Developments International posts Q1 revenue growth and strong cash flow; advances Penthrox paediatric approvals
10 Oct 2025
·Quarterly Activity Report and Appendix 4C
·80
MVP Boosts Cashflow and Expands Penthrox Reach in Europe and AustraliaMedium
MVP delivers positive H2 FY25 cashflow, revenue growth, and successful European distribution transition
31 July 2025
·Quarterly Activity Report and Appendix 4C
·80
MVP Boosts Penthrox Sales Amid EBIT Challenges in FY26 H1Medium
MVP H1 FY26 revenue up 8%, Penthrox volume growth strong; EBIT loss narrows excluding FX impact
19 Feb 2026
·Half Year Results
·75
Medical Developments Reports Positive Cashflow and Strong Penthrox Growth in H1 FY26Medium
Medical Developments International posts positive H1 cashflow, Penthrox volume growth, and advances paediatric approvals
30 Jan 2026
·Quarterly Activity Report and Appendix 4C
·75
No articles in this tier for the last 12 months.
Market Mentions
1
- appeared in market wrap coverage
These are market wrap articles where Medical Developments International (ASX:MVP) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026